Directors need to come out with more than $$$ to support a...

Directors need to come out with more than $$$ to support a falling SP - they need to come out with some hard data showing that Ropren has clinical efficacy in treating liver disease. Until then all the pricing info they put out is just an academic exercise hence the SLA brainwashed should build that into your future SP projections at peril as the Western world won't be paying thousands of dollars for a treatment that doesn't have clinical efficacy data behind it. Blood test results just aren’t going to cut it – need biopsies showing cellular changes in hepatocyte function and liver morphology to support claims that it cures liver disease and SLA just don’t have that data.